Healthy Longevity Clinic

From longevity science to human evidence and care

Our relationship with Longevitytech.fund connects a global network of scientists and biotechnology companies with HLC’s clinical teams, diagnostics and ongoing care. It gives us a practical role in learning how promising science translates into people’s lives.

Early insight through direct scientific relationships

Longevitytech.fund’s portfolio and wider scientific network bring sustained contact with founders, researchers and emerging platforms. HLC can discuss the underlying mechanisms, the available evidence and the questions still to be answered directly with the teams developing them. This informs the selection of research opportunities and our understanding of the field. Dr. Ana Baroni is Healthy Longevity Clinic’s Chief Medical Officer and Longevitytech.fund’s Chief Scientific Officer. Meet Longevitytech.fund’s scientific team

The ability to move from a research question to human data

HLC contributes clinical facilities, medical expertise, participant coordination and longitudinal follow-up to selected research work, including carefully designed first-in-human evaluation. A defined question is paired with the applicable research pathway, appropriate participants, responsible professionals and a measurement plan. This is how scientific access can become useful human evidence.

Several ways to measure what changes

Clinical laboratory results, biological-age platforms, organ-system analysis and functional tests can examine different aspects of a response. Looking across these measures helps the team assess positive findings alongside unchanged, unfavorable or uncertain results.

Learning that can improve future protocols

Findings feed back to researchers and clinical teams. They can refine monitoring, participant selection, follow-up and future protocol design. Prague provides an advanced clinical and translation base; Miami is HLC’s US flagship for advanced assessment, treatment and ongoing care, while Boca Raton contributes consultation and continuity care.

What this means for you

You gain a clinical relationship informed by direct scientific dialogue, careful measurement and a view of where longevity medicine is heading. Your physician translates that perspective into advice appropriate to your health. Participation in research follows a separate assessment, consent and oversight process; clinical recommendations are guided by evidence and individual suitability. Explore a coordinated assessment · Explore HLC Signature

A working connection between discovery and care

HLC × Longevitytech.fund Explore Longevitytech.fund

Decide your next step with a physician

Begin with the Healthy Longevity Plan, or arrange a private conversation about broader assessment and ongoing care.